Jagsonpal Pharmaceuticals informs about updates

Jagsonpal Pharmaceuticals Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 507789 | NSE: JAGSNPHARM

07 Oct 2025 Evaluate

Jagsonpal Pharmaceuticals has informed that consequent to the appointment of Nirav Niranjankumar Vora as Chief Financial Officer, the Board of Directors have approved changes in KMPs authorized for the purpose of determining the materiality of an event or information and for the purpose of making disclosures to stock exchange(s) under the SEBI (LODR). The contact details of the KMPs authorized are as enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers

Company Name	CMP
Sun Pharma. Inds.	1840.00
Dr. Reddys Labs.	1222.50
Cipla	1388.90
Lupin	2061.85
Zydus Lifesciences	1212.00
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.